Evidence map›Paper›PMID 35850040›Full record

ArticleBiosensors & bioelectronics2022

Directly immersible silicon photonic probes: Application to rapid SARS-CoV-2 serological testing.

Michailia Angelopoulou, Eleni Makarona, Alexandros Salapatas, Konstantinos Misiakos, Evgenia Synolaki, Anastasios Ioannidis, Stylianos Chatzipanagiotou, Mikael A Ritvos, Arja Pasternack, Olli Ritvos and 2 more

Abstract read
In one paragraph

Article in Biosensors & bioelectronics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Michailia AngelopoulouInstitute of Nuclear & Radiological Science & Technology, Energy & Safety, NCSR "Demokritos", Aghia Paraskevi, 15341, Greece.
Eleni MakaronaInstitute of Nanoscience and Nanotechnology, NCSR "Demokritos", Aghia Paraskevi, 15341, Greece.
Alexandros SalapatasInstitute of Nanoscience and Nanotechnology, NCSR "Demokritos", Aghia Paraskevi, 15341, Greece.
Konstantinos MisiakosInstitute of Nanoscience and Nanotechnology, NCSR "Demokritos", Aghia Paraskevi, 15341, Greece.
Evgenia SynolakiCentre for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, 11527, Greece.
Anastasios IoannidisDepartment of Nursing, Faculty of Health Sciences, University of Peloponnese, Tripoli, 22100, Greece.
Stylianos ChatzipanagiotouDepartment of Medical Biopathology and Clinical Microbiology, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, 11528, Greece.
Mikael A RitvosDepartment of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland; School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Stockholm, Sweden; Nordic SARS Response AB, Stockholm, 19455, Sweden.
Arja PasternackDepartment of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland.
Olli RitvosDepartment of Physiology, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland.
Panagiota S PetrouInstitute of Nuclear & Radiological Science & Technology, Energy & Safety, NCSR "Demokritos", Aghia Paraskevi, 15341, Greece. Electronic address: ypetrou@rrp.demokritos.gr.
Sotirios E KakabakosInstitute of Nuclear & Radiological Science & Technology, Energy & Safety, NCSR "Demokritos", Aghia Paraskevi, 15341, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silicon photonic probes based on broad-band Mach-Zehnder interferometry are explored for the first time as directly immersible immunosensors alleviating the need for microfluidics and pumps. Each probe includes two U-shaped waveguides allowing light in- and out-coupling from the same chip side through a bifurcated fiber and a mechanical coupler. At the opposite chip side, two Mach-Zehnder interferometers (MZI) are located enabling real-time monitoring of binding reactions by immersion of this chip side into a sample. The sensing arm windows of the two MZIs have different length resulting in two distinct peaks in the Fourier domain, the phase shift of which can be monitored independently through Fast Fourier Transform of the output spectrum. The photonic probes analytical potential was demonstrated through detection of antibodies against SARS-CoV-2 in human serum samples. For this, one MZI was functionalized with the Receptor Binding Domain (RBD) of SARS-CoV-2 Spike 1 protein, and the other with bovine serum albumin to serve as reference. The biofunctionalized probes were immersed for 10 min in human serum sample and then for 5 min in goat anti-human IgG Fc specific antibody solution. Using a humanized rat antibody against SARS-CoV-2 RBD, a detection limit of 20 ng/mL was determined. Analysis of human serum samples indicated that the proposed sensor discriminated completely non-infected/non-vaccinated from vaccinated individuals, and the antibodies levels determined correlated well with those determined in the same samples by ELISA. These results demonstrated the potential of the proposed sensor to serve as an efficient tool for expeditious point-of-care testing.

Indexed as

Biosensing TechniquesCOVID-19AnimalsAntibodiesAntibodies, ViralCOVID-19 TestingHumansImmunoassayRatsSARS-CoV-2SiliconAntibodiesAntibodies, ViralSiliconBroad-band Mach-Zehnder interferometryImmersible sensorLabel-free detectionSARS-CoV-2 antibodySilicon nitride waveguides

Identifiers

PMID35850040
PMCPMC9273522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.